HRMY Jan 2025 22.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:19AM EDT. Market open.
| Previous Close | 10.14 |
| Open | 10.14 |
| Bid | 7.50 |
| Ask | 12.00 |
| Strike | 22.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 10.14 - 10.14 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
PR NewswireHARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1
Harmony Biosciences (Nasdaq: HRMY) presented data from its Phase 2 signal detection study showing that pitolisant reduced excessive daytime sleepiness (EDS) and fatigue in adults with Myotonic dystrophy Type 1 (DM1).
- PR Newswire
HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, FL on Monday, June 10, 2024, at 9:20 a.m. ET.
Simply Wall St.Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Investors in Harmony Biosciences Holdings, Inc. ( NASDAQ:HRMY ) had a good week, as its shares rose 7.7% to close at...
© 2024 Yahoo. All rights reserved.